BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Quill Medical, Inc.'s Novel Self-Anchoring Surgical Suture Approved For Sale In Europe


10/19/2005 5:11:18 PM

RESEARCH TRIANGLE PARK, N.C., May 10 /PRNewswire/ -- Quill Medical, Inc. today announced that it has received CE Marking for its Quill(TM) Barbed Polydioxanone Suture, used in dermal closure. The CE Mark allows Quill Medical to market its Barbed Polydioxanone Sutures throughout Europe. The product is first in a series of tissue repair devices based on a proprietary technology that enables sutures to "self-anchor" in tissue without the need for a conventional suture knot.

"Devices that eliminate the painstaking step of suture knot-tying would benefit nearly all fields of surgery," said Matthew Megaro, Quill Medical President and CEO. He added, "We are developing a range of such products for use in many specialized and commercially important surgical applications."

This CE Mark approval resulted from the review and evaluation of technical and clinical data developed through multi site testing of the Barbed Polydioxanone Suture. CE Marking on a product is a manufacturer's declaration that the product complies with essential health and safety requirements for marketing and distribution throughout the 25 countries that comprise the European Union.

About Quill Medical

Quill Medical is a North Carolina-based medical device company developing innovative surgical aids based on its novel and proprietary knot-less, self- anchoring suture technology. The company's products target diverse applications in the fields of wound closure, orthopedic and cosmetic surgery. For more information, visit http://www.quillmedical.com/ .

About TUV America Inc. (Medical Unit)

TUV America Inc., Product Service division, is a leading EU Notified Body for the Medical Devices, Active Implantable Medical Devices and In Vitro Diagnostic Directives. TUV also provides ISO 9000, ISO 13485/88, EN 46000 and ISO 14001 certification; SCC qualified ISO 13485 Registrar for the Canadian Medical Devices Regulations; FDA 510(k) reviews; electromagnetic compatibility (EMC); NRTL certification to ANSI/UL 2601; electrical, mechanical and functional safety testing; and many additional global conformity assessment services. Globally, TUV has issued over 130,000 product and 12,000 quality management system certifications. For more information, visit http://www.tuvamerica.com/ .

Quill Medical, Inc.

CONTACT: Matthew Megaro, President and CEO of Quill Medical, Inc.,+1-919-806-1961



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES